Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia
Siegfried Kasper, Anthony Hale, Jean-Michel Azorin, Hans-Jürgen MüllerVolume:
249
Language:
english
Pages:
1
DOI:
10.1007/pl00014165
Date:
November, 1999
File:
PDF, 343 KB
english, 1999